Conn. Cities' Insulin Pricing Suits Against PBMs Join NJ MDL
By Aaron Keller · September 25, 2025, 2:34 PM EDT
Two Connecticut cities' civil racketeering and state trade practices law claims against insulin manufacturers Eli Lilly and Co., Novo Nordisk Inc. and Sanofi-Aventis US LLC, and pharmacy benefit managers CVS Caremark,...
To view the full article, register now.